Results 241 to 250 of about 210,758 (351)

Health-Related Social Needs during the COVID-19 Pandemic: The Chronic Renal Insufficiency Cohort (CRIC) Study. [PDF]

Kidney360
Novick TK, Osuna-Diaz M, Appel LJ, Charleston JB, Lash JP, Meza N, Cohen DL, Allen A, Crews DC, CRIC Study Investigators.   +9 more
europepmc   +1 more source

Evaluating and leveraging large language models in clinical pharmacology and therapeutics assessment: From exam takers to exam shapers

British Journal of Clinical Pharmacology, EarlyView.
Aims In medical education, the ability of large language models (LLMs) to match human performance raises questions about their potential as educational tools. This study evaluates LLMs' performance on Clinical Pharmacology and Therapeutics (CPT) exams, comparing their results to medical students and exploring their ability to identify poorly formulated
Alexandre O. Gérard, Diane Merino, Marc Labriffe, Fanny Rocher, Delphine Viard, Laurence Zemori, Thibaud Lavrut, Erik M. Donker, Joost D. Piët, Jean‐Paul Fournier, Milou‐Daniel Drici, Alexandre Destere   +11 more
wiley   +1 more source

Organic Pollutant Exposure and CKD: A Chronic Renal Insufficiency Cohort Pilot Study. [PDF]

Kidney Med
Charytan DM, Wu W, Liu M, Li ZM, Kannan K, Trasande L, Pal VK, Lee S, Trachtman H, CRIC Study Investigators.   +9 more
europepmc   +1 more source

Avoiding infrainguinal bypass wound complications in patients with chronic renal insufficiency: The role of the anatomic plane

, 1996
Jan D. Blankensteijn, Jonathan P. Gertler, Michael J. Petersen, D C Brewster, Richard P. Cambria, Glenn M. LaMuraglia, William M. Abbott   +6 more
openalex   +1 more source

Management of disturbances of calcium and phosphate metabolism in chronic renal insufficiency, with emphasis on the control of hyperphosphataemia [PDF]

, 2002
Francesco Locatelli
openalex   +1 more source

Population pharmacokinetic modelling revealed large variability in oromucosal absorption of Δ9‐tetrahydrocannabinol in older patients with poor appetite

British Journal of Clinical Pharmacology, EarlyView.
Aim Cannabis‐based medicines are gaining interest and being explored for new therapeutic indications, many of which commonly affect older medical patients. As most previous studies of the population pharmacokinetics of cannabinoids have been performed in healthy adults, this study aimed to investigate the population pharmacokinetics of Δ9 ...
Ida Klitzing Storgaard, Rikke Lundsgaard Nielsen, Morten Baltzer Houlind, Olivia Bornæs, Louise Westberg Strejby Christensen, Aino Leegaard Andersen, Helle Gybel Juul‐Larsen, Lillian Mørch Jørgensen, Torben Breindahl, Baker Nawfal Jawad, Izzet Altintas, Ove Andersen, Trine Meldgaard Lund   +12 more
wiley   +1 more source

The influence of chronic renal insufficiency on multi-therapeutic modalities for breast cancer: a single-center experience. [PDF]

Breast Cancer
Hong YW, Kuo IM, Kuo WL, Yu CC, Shen SC, Tsai HP, Chu CH, Ho HY, Lo YF, Chen SC, Lin YC, Chien CY, Chou HH.   +12 more
europepmc   +1 more source

Efficacy and safety of empagliflozin for treating neutropenia and neutrophil dysfunction in paediatric patients with glycogen storage disease type Ib: A systematic review and meta‐analysis

British Journal of Clinical Pharmacology, EarlyView.
Aims Glycogen storage disease type Ib (GSD‐Ib) is a rare genetic disorder causing neutropenia and neutrophil dysfunction in children. G‐CSF has been the primary treatment, but emerging data support the potential of empagliflozin, an SGLT2 inhibitor, as a promising investigational option.
Elizabeth Iwasyk, Ryan Jin, Fabio Tuzzolino, Giusy Ranucci, Donatella Madonia, Alessio Provenzani   +5 more
wiley   +1 more source

Tophaceous gout of the extensor mechanism of the knee [PDF]

, 2015
Catry, F, Vanhoenacker, Filip, Vansevenant, Milan   +2 more
core   +2 more sources

Pharmacokinetics of teicoplanin in paediatric patients—A systematic review of current literature

British Journal of Clinical Pharmacology, EarlyView.
Background and Objective Teicoplanin is commonly used in children to treat gram‐positive infections and is sometimes used off‐label prophylactically in surgical or paediatric oncology settings. The pharmacokinetics (PK) of teicoplanin in children exhibit considerable variability, such as in critically ill children or those with renal impairment.
Noa E. Wijnen, Daan J. Touw, Kim Klein, Gertjan J. L. Kaspers, Paola Mian   +4 more
wiley   +1 more source